Inhaled insulin: overview of a novel route of insulin administration

References

• Centers for Disease Control and PreventionNational diabetes fact sheet: general information and national estimates on diabetes in the United States. 2007Atlanta, GAUS Department of Health and Human Services, Centers for Disease Control and Prevention2008 URL. http://www.cdc.gov/diabetes/pubs/factsheet07.htm. Accessed August 26, 2009.
   Google Scholar
• BakkerWEringaECSipkemaPvanHinsberghVWEndothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesityCell Tissue Res2009335116518918941783
   PubMed Web of Science ®Google Scholar
• StamlerJVaccaroONeatonJDWentworthDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care19931624344448432214
   PubMed Web of Science ®Google Scholar
• KrolewskiASKosinskiEJWarramJHMagnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusAm J Cardiol19875987507553825934
   PubMed Web of Science ®Google Scholar
• LaingSPSwerdlowAJSlaterSDMortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetesDiabetologia200346676076512774166
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research GroupThe effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitusN Engl J Med1993329149779868366922
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet199835291318378539742976
   PubMed Web of Science ®Google Scholar
• ZambaniniANewsonRBMaiseyMFeherMDInjection related anxiety in insulin-treated diabetesDiabetes Res Clin Pract199946323924610624790
   PubMed Web of Science ®Google Scholar
• PrentkiMMatschinskyFMCa2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretionPhysiol Rev1987674118512482825225
   PubMed Web of Science ®Google Scholar
• PorteDSherwinRBaronAEllenberg and Rifkin’s Diabetes Mellitus6th edNew YorkMcGraw-Hill20034365
   Google Scholar
• ClincalTrialsgov [homepage on the Internet] A service of the US National Institutes of Health [updated October 13, 2009]. URL: http://clinicaltrials.gov/ct2/show/NCT00668850 Accessed October 14, 2009.
   Google Scholar
• LogtenbergSJKleefstraNHouwelingSTImproved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes:a randomized controlled trialDiabetes Care20093281372137719429874
   PubMed Web of Science ®Google Scholar
• LaqueurEGrevenstukAUber die wirkunk intratrachealer zuführung von insulinKlin Wochenschr1924312731274
   Google Scholar
• GänsslenMUber inhalation von insulinKlin Wochenschr1925471
   Google Scholar
• PattonJSByronPRInhaling medicines: delivering drugs to the body through the lungsNat Rev Drug Discov200761677417195033
   PubMed Web of Science ®Google Scholar
• UsmaniOSBiddiscombeMFBarnesPJRegional lung deposition and bronchodilator response as a function of beta2-agonist particle sizeAm J Respir Crit Care Med2005172121497150416192448
   PubMed Web of Science ®Google Scholar
• KatzIMSchroeterJDMartonenTBFactors affecting the deposition of aerosolized insulinDiabetes Technol Ther20013338739711762517
   PubMedGoogle Scholar
• FarrSJMcElduffAMatherLEPulmonary insulin administration using the AERx system: physiological and physiochemical factors influencing insulin effectiveness in healthy fasting subjectsDiabetes Technol Ther20002218519711469258
   PubMedGoogle Scholar
• BlissMThe Discovery of InsulinChicago, ILUniversity of Chicago Press1982
   Google Scholar
• HeubnerWde JonghSLaquerEUber inhalation von insulinKlin Wochenschr1924323422343
   Google Scholar
• ElliottRBEdgarBWPilcherCCQuestedCMcMasterJParenteral absorption of insulin from the lung in diabetic childrenAust Paediatr J19872352932973326575
   PubMedGoogle Scholar
• PattonJSBukarJGEldonMAClinical pharmacokinetics and pharmacodynamics of inhaled insulinClin Pharmacokinet2004431278180115355125
   PubMed Web of Science ®Google Scholar
• RosenstockJBergenstalRDeFronzoRAEfficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agentsDiabetes Care200831112177218218678610
   PubMed Web of Science ®Google Scholar
• RaveKHeiseTPfutznerABossAHCoverage of postprandial blood glucose excursions with inhaled Technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetesDiabetes Care20073092307230817586744
   PubMed Web of Science ®Google Scholar
• ClincalTrialsgov [homepage on the Internet] A service of the US National Institutes of Health. URL: www.ClinicalTrials.gov/ct2/results?term=inhaled+insulin Accessed September 23, 2009.
   Google Scholar
• GargSKKellyWCInsulin delivery via lungs – is it still possible?Diabetes Technol Ther200911Suppl 2S1S3
   PubMedGoogle Scholar
• RaveKBottSHeinemannLTime-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulinDiabetes Care20052851077108215855570
   PubMed Web of Science ®Google Scholar
• RaveKPotockaEBossAHMarinoMCostelloDChenRPharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulinDiabetes Obes Metab200911771572019476477
   PubMed Web of Science ®Google Scholar
• BrunnerGABalentBEllmererMDose-response relation of liquid aerosol inhaled insulin in Type 1 diabetic patientsDiabetologia200144330530811317660
   PubMed Web of Science ®Google Scholar
• CefaluWTSkylerJSKouridesIAInhaled human insulin treatment in patients with type 2 diabetes mellitusAnn Intern Med2001134320320711177333
   PubMed Web of Science ®Google Scholar
• RaveKNosekLDe la PenaADose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lisproDiabetes Care2005282400240516186270
   PubMed Web of Science ®Google Scholar
• de la PenaASegerMRaveKHeinemannLSilvermanBMuchmoreDBAIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamicsDiabetes Technol Ther200911S2S75S7919772452
   PubMedGoogle Scholar
• RoylePWaughLMcAuleyLMcIntyreLThomasSInhaled insulin in diabetes mellitusCochrane Database Syst. Rev2004CD00389015266506
   PubMedGoogle Scholar
• SkylerJSWeinstockRSRaskinPUse of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjectsDiabetes Care20052871630163515983312
   PubMed Web of Science ®Google Scholar
• QuattrinTBelangerABohannonNJVSchwartzSLEfficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetesDiabetes Care200427112622262715504996
   PubMed Web of Science ®Google Scholar
• GargSKMathieuCRaisNTwo-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trialDiabetes Technol Ther200911S2S5S1619772449
   PubMedGoogle Scholar
• BergenstalRMKapsnerPLRendellMSComparative efficacy and safety of AFRESA and a rapid-acting analog both given with glargine in subjects with T1DM in a 52-week studyDiabetes2009A479
   PubMedGoogle Scholar
• RosenstockJZinmanBMurphyLJInhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trialAnn Intern Med2005143854955816230721
   PubMed Web of Science ®Google Scholar
• HollanderPABlondeLRoweREfficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetesDiabetes Care200427102356236215451900
   PubMed Web of Science ®Google Scholar
• HermansenKRönnemaaTPetersenAHBellaireSAdamsonUIntensive therapy with inhaled insulin via the AERx insulin diabetes management systemDiabetes Care200427116216714693983
   PubMed Web of Science ®Google Scholar
• RosenstockJEliaschewitzFHeilmannCMuchmoreDBHayesRBelinRComparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargineDiabetes Technol Ther200911S2S63S7319772451
   PubMedGoogle Scholar
• RosenstockJCapelleriJCBolinderBGerberRAPatient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetesDiabetes Care20042761318132315161782
   PubMed Web of Science ®Google Scholar
• FordESMokdadAHGreggEWTrends in cigarette smoking among US adults with diabetes: findings from the Behavioral Risk Factor Surveillance SystemPrev Med20043961238124215539062
   PubMed Web of Science ®Google Scholar
• WiseSChienJYeoKRichardsonCSmoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly-Dura inhaled insulin systemDiabet Med200623551051516681559
   PubMed Web of Science ®Google Scholar
• HimmelmannAJendleJMellénAPetersenAHDahlULWolmerPThe impact of smoking on inhaled insulinDiabetes Care200326367768212610021
   PubMed Web of Science ®Google Scholar
• BeckerRHShaSFrickADFountaineRJThe effect of smoking cessation and subsequent resumption on absorption of inhaled insulinDiabetes Care200629227728216443873
   PubMed Web of Science ®Google Scholar
• TargherGAlbericheMZenereMBBonadonnaRCMuggeoMBonoraECigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitusJ Clin Endocrinol Metab19978211361936249360516
   PubMed Web of Science ®Google Scholar
• FountaineRMiltonAChecchioTAcute passive cigarette smoke exposure and inhaled human insulin (Exubera) pharmacokineticsBr J Clin Pharmacol200865686487018477263
   PubMed Web of Science ®Google Scholar
• KlingJInhaled insulin’s last gasp?Nat Biotech2008265479480
   PubMed Web of Science ®Google Scholar
• McElduffAMatherLEKamPCClausonPInfluence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management SystemBr J Clin Pharmacol200559554655115842553
   PubMed Web of Science ®Google Scholar
• WolztMde la PenaABerclazPYTibaldiFSGatesJRMuchmoreDBAIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics and pulmonary function in asthmaDiabetes Care200831473574018192544
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension, and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• RaveKde la PenaATibaldiFSAIR inhaled insulin in subjects with chronic obstructive pulmonary diseaseDiabetes Care20073071777178217456839
   PubMed Web of Science ®Google Scholar
• McGrathMWThomsonMLThe effect of age, body size and lung volume change on alveolar-capillary permeability and diffusing capacity in manJ Physiol1959146357258213665679
   PubMed Web of Science ®Google Scholar
• HenryRRMudalierSChuNYoung and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparisonJ Clin Pharmacol200343111228123414551177
   PubMed Web of Science ®Google Scholar
• SkylerJSCefaluWTKouridesIAEfficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept studyLancet2001357925333133511210993
   PubMed Web of Science ®Google Scholar
• BarnettAHLangePDreyerMSerdarevic-PeharMLong-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetesInt J Clin Pract200761101614162517877648
   PubMed Web of Science ®Google Scholar
• DavisWAKnuimanMKendalPGrangeVDavisTMGlycemic exposure is associated with reduced pulmonary function in type 2 diabetes The Fremantle Diabetes StudyDiabetes Care200427375275714988297
   PubMed Web of Science ®Google Scholar
• SkylerJSSustained long-term efficacy and safety of inhaled insulin during 4 years of continuous therapyDiabetes200453A115
   Web of Science ®Google Scholar
• Dahl-JørgensenKTorjesenPHanssenKFSandvikLAagenaesOIncrease in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatmentDiabetes1987361153539672
   PubMed Web of Science ®Google Scholar
• Lassmann-VagueVBelicarPRaccahDVialettesBSodoyezJCVaguePImmunogenicity of long-term intraperitoneal insulin adminstration with implantable programmable pumps: metabolic consequencesDiabetes Care19951844985037497859
   PubMed Web of Science ®Google Scholar
• SchernthanerGImmunogenicity and allergenic potential of animal and human insulinsDiabetes Care 63.199316Suppl 31551658299472
   PubMedGoogle Scholar
• WalfordSAllisonSPReevesWGThe effect of insulin antibodies on insulin dose and diabetic controlDiabetologia19822221061107037511
   PubMed Web of Science ®Google Scholar
• PetersAKloseOHeftyRKeckFKernerWThe influence of insulin antibodies on the pharmacokinetics of NPH insulin in patients with type 1 diabetes treated with human insulinDiabet Med199512109259308846686
   PubMed Web of Science ®Google Scholar
• SeewiOJaegerCBretzelRGSchönauEInsulin binding to antibodies is a risk factor for inexplicable severe hypoglycaemia in children with type-1 diabetes mellitusExp Clin Endocrinol Diabetes2008116529329718484562
   PubMed Web of Science ®Google Scholar
• KimMRSheelerLRMansharamaniNHaugMTFaimanCGuptaMKInsulin antibodies and hypoglycemia in diabetic patients. Can a quantitiative analysis of antibody binding predict the risk of hypoglycemia?Endocrine1997632852919368685
   PubMed Web of Science ®Google Scholar
• FinebergSEKawabataTFinco-KentDLiuCKrasnerAAntibody response to inhaled insulin in patients with type 1 or type 2 diabetesJ Clin Endocrinol Metab20059063287329415741258
   PubMed Web of Science ®Google Scholar
• WolffRKSafety of inhaled proteins for therapeutic useJ Aerosol Med199811419721910346664
   PubMedGoogle Scholar
• FreemantleNBlondeLDuhotDAvailability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetesDiabetes Care200528242742815677807
   PubMed Web of Science ®Google Scholar
• BergenstalRFreemantleNLeykMCutlerGHayesRMuchmoreDBDoes availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetesDiabetes Technol Ther200911S2S45S5219772448
   PubMedGoogle Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749616079372
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
   PubMed Web of Science ®Google Scholar
• CramerJAOkikawaJBellaireSClausonPCompliance with inhaled insulin treatment using the AERx iDMS insulin diabetes management systemDiabetes Technol Ther20046680080715684632
   PubMedGoogle Scholar
• BlackCCumminsERoylePPhilipSWaughNThe clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluationHealth Technol Assess20071133112617767897
   PubMed Web of Science ®Google Scholar